Concepedia

I. Hennig

IH

Statistics

Publications

22

Citations

1.3K

H-Index

19

Active since

1992

Affiliations

Nottingham University Hospitals NHS Trust(Current)

University of Bern

The Christie NHS Foundation Trust

University College London

University of Nottingham

I. Hennig is an author at Nottingham University Hospitals NHS Trust specializing in oncology, medicine, and pharmacology.

Publications per year

1992–2022

22

Publications

22

Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization

I. Hennig, Jean A. Laissue, U Horisberger et al. · International Journal of Cancer · 1995 · 206 citations

Medicine, Oncology, Pharmacology +14

Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)

Ronald B. Keus, Remi A. Nout, Jean‐Yves Blay et al. · Annals of Oncology · 2013 · 136 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines.

Atheer Zgair, Jonathan C.M. Wong, Jong Bong Lee et al. · PubMed · 2016 · 133 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation

Atheer Zgair, Jong Bong Lee, Jonathan C.M. Wong et al. · Scientific Reports · 2017 · 127 citations · Full text

Medicine, Immunology, Pharmacology +8

Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

Ian Judson, James P. Morden, Lucy Kilburn et al. · The Lancet Oncology · 2019 · 98 citations · Full text

Medicine, Oncology, Pharmacology +11

1–5 of 22